KCM
BHVN

KRS Capital Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

KRS Capital Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,355
Closed -$204K – 110
2022
Q3 		$204K Sell
1,355
-2,460
-64% -$370K 0.28% 93
2022
Q2 		$555K Sell
3,815
-2,003
-34% -$291K 0.79% 36
2022
Q1 		$689K Sell
5,818
-35
-0.6% -$4.15K 0.75% 36
2021
Q4 		$806K Buy
+5,853
New +$806K 0.69% 34